Skip to Main Content
Skip Nav Destination

Online First / Early View

Online first articles are accepted and edited, peer reviewed articles that are not yet assigned to volumes/issues, but are citable using DOI.

Online First

Review Articles April 18 2024
Proton Pump Inhibitors and Kidney Disease: Fact or Fiction?
Am J Nephrol (2024) https://doi.org/10.1159/000538755
Research Articles March 29 2024
Association of Sevelamer Initiation with Gastrointestinal Bleeding Hospitalization in Individuals Requiring Hemodialysis
Am J Nephrol (2024) https://doi.org/10.1159/000538253
Research Articles March 18 2024
Acute and Chronic Kidney Dysfunction and Prognosis following Thrombectomy for Ischemic Stroke
Am J Nephrol (2024) https://doi.org/10.1159/000536493
Research Articles March 18 2024
The Risk Factors and Clinical Outcomes in Hepatitis B Seropositive and Seronegative Renal Transplant Patients
Am J Nephrol (2024) https://doi.org/10.1159/000538231
Review Articles March 18 2024
Onco-Hypertension in Patients with Kidney Disease
Am J Nephrol (2024) https://doi.org/10.1159/000538375
Brief Reports March 12 2024
Diagnostic Yield of Exome Sequencing in Early-Onset Hypertensive Nephropathy in Adults
Am J Nephrol (2024) https://doi.org/10.1159/000538173
Systematic Review March 12 2024
Association of Proton Pump Inhibitor Use and Immune Checkpoint Inhibitor-Mediated Acute Kidney Injury: A Meta-Analysis and a Review of Related Outcomes
Am J Nephrol (2024) https://doi.org/10.1159/000538274
Review Articles March 3 2024
Deliverables from Metabolomics in Kidney Disease: Adenine, New Insights, and Implication for Clinical Decision-Making
Am J Nephrol (2024) https://doi.org/10.1159/000538051
Methods Article February 29 2024
Rilparencel (Renal Autologous Cell Therapy-REACT®) for Chronic Kidney Disease and Type 1 and Type 2 Diabetes: Phase 2 Trial Design Evaluating Bilateral Kidney Dosing and Redosing Triggers
Am J Nephrol (2024) https://doi.org/10.1159/000537942
Commentaries February 28 2024
Expanding the Impact of SGLT2 Inhibitors in Chronic Kidney Disease
Am J Nephrol (2024) https://doi.org/10.1159/000536540
Research Articles February 20 2024
Musculoskeletal Health Worsened from Carnitine Supplementation and Not Impacted by a Novel Individualized Treadmill Training Protocol
Am J Nephrol (2024) https://doi.org/10.1159/000537827
Corrections/Errata February 16 2024
Erratum - Intrarenal Anti-Leptin Treatment Attenuates Ischemia and Reperfusion Injury
Am J Nephrol (2024) https://doi.org/10.1159/000536477
Research Articles February 11 2024
Availability and Quality of Dialysis Care in Rural versus Urban US Counties
Am J Nephrol (2024) https://doi.org/10.1159/000537763
Research Articles February 8 2024
Klotho Stabilizes the Podocyte Actin Cytoskeleton in Idiopathic Membranous Nephropathy through Regulating the TRPC6/CatL Pathway
Am J Nephrol (2024) https://doi.org/10.1159/000537732
Brief Reports February 2 2024
Association between Serum 25-Hydroxyvitamin D Levels and Sarcopenia in Patients Undergoing Chronic Haemodialysis
Am J Nephrol (2024) https://doi.org/10.1159/000536582
Brief Reports January 22 2024
Difelikefalin in Black/African American Hemodialysis Patients with Moderate-to-Severe Pruritus: Post hoc Analysis of KALM-1 and KALM-2
Am J Nephrol (2024) https://doi.org/10.1159/000534227
Expressions of Concern January 19 2024
Expression of concern - Agonists of Peroxisome-Proliferator Activated Receptor-Gamma Reduce Renal Ischemia/Reperfusion Injury
Am J Nephrol (2024) https://doi.org/10.1159/000536261
Research Articles January 16 2024
Amide Proton Transfer-Weighted Magnetic Resonance Imaging for Application in Renal Fibrosis: A Radiological-Pathological-Based Analysis
Am J Nephrol (2024) https://doi.org/10.1159/000536232
Commentaries January 10 2024
Klotho and Mortality in Chronic Kidney Disease: Actor, Risk Factor, or Predictor?
Am J Nephrol (2024) https://doi.org/10.1159/000535752
Research Articles January 9 2024
PKD1 Truncating Mutations Accelerate eGFR Decline in Autosomal Dominant Polycystic Kidney Disease Patients
Am J Nephrol (2024) https://doi.org/10.1159/000536165
Review Articles December 18 2023
Equity and Quality of Global Chronic Kidney Disease Care: What Are We Waiting for?
Am J Nephrol (2023) https://doi.org/10.1159/000535864
Research Articles December 16 2023
Association between Serum Klotho and All-Cause Mortality in Chronic Kidney Disease: Evidence from a Prospective Cohort Study
Am J Nephrol (2023) https://doi.org/10.1159/000535808
Commentaries August 31 2023
One More Step in the Renal Denervation Trek
Am J Nephrol (2023) https://doi.org/10.1159/000533885
Research Articles August 31 2023
Durability of the Blood Pressure Effects of Renal Pelvic Denervation in Patients with Hypertension during a 12-Month Observation
Am J Nephrol (2023) https://doi.org/10.1159/000533569

Early View

Research Articles May 16 2024
Effect of End-Stage Renal Disease Prospective Payment System on Utilization of Peritoneal Dialysis in Patients with Kidney Allograft Failure
Am J Nephrol (2024) https://doi.org/10.1159/000539062
Brief Reports May 14 2024
Safety profile and effectiveness of dapagliflozin in pediatric patients with chronic kidney disease
Am J Nephrol (2024) https://doi.org/10.1159/000539300
Research Articles April 26 2024
The predictors and risk factors of two-year rejection in renal transplant patients: A multicenter case-control study
Am J Nephrol (2024) https://doi.org/10.1159/000538963
Close Modal

or Create an Account

Close Modal
Close Modal